HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeda Xiao Selected Research

Toll-Like Receptor 7

9/2019TLR7 mediates increased vulnerability to ischemic acute kidney injury in diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeda Xiao Research Topics

Disease

2Hypoxia (Hypoxemia)
12/2019 - 09/2019
2Inflammation (Inflammations)
09/2019 - 02/2019
1Pain (Aches)
07/2021
1Postoperative Pain
07/2021
1Diabetes Mellitus
01/2020
1Ischemia
09/2019
1Neuralgia (Stump Neuralgia)
01/2018
1Hyperalgesia
01/2018

Drug/Important Bio-Agent (IBA)

1Lidocaine (Xylocaine)FDA LinkGeneric
07/2021
1Opioid Analgesics (Opioids)IBA
07/2021
1Streptozocin (Streptozotocin)FDA Link
01/2020
1pyrazolanthroneIBA
12/2019
1Propofol (Diprivan)FDA LinkGeneric
12/2019
1Toll-Like Receptor 7IBA
09/2019
1Glucose (Dextrose)FDA LinkGeneric
09/2019
1Proteins (Proteins, Gene)FDA Link
09/2019
1CytokinesIBA
02/2019
1Polysaccharides (Glycans)IBA
02/2019
1AntioxidantsIBA
02/2019
1DexmedetomidineFDA Link
01/2018
1Cyclic NucleotidesIBA
01/2018
1ICI D2788IBA
01/2018

Therapy/Procedure

1Intraperitoneal Injections
01/2020